Cargando…
Multiple sclerosis following SARS-CoV-2 infection
SARS-CoV-2 infection can produce neurological features. The most common are headache, anosmia and dysgeusia but patients may also develop other central nervous system (CNS) injuries. We present a patient affected by Covid-19 who initially consulted for decreased visual acuity. The MRI showed inflamm...
Autores principales: | Palao, M., Fernández-Díaz, E., Gracia-Gil, J., Romero-Sánchez, C.M., Díaz-Maroto, I., Segura, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7340057/ https://www.ncbi.nlm.nih.gov/pubmed/32698095 http://dx.doi.org/10.1016/j.msard.2020.102377 |
Ejemplares similares
-
COVID-19 and multiple sclerosis: A description of two cases on alemtuzumab
por: Fernández-Díaz, Eva, et al.
Publicado: (2020) -
SARS-CoV-2 Infection and Risk Management in Multiple Sclerosis
por: Diaz de la Fe, Amado, et al.
Publicado: (2021) -
SARS-CoV-2 triggered relapse of multiple sclerosis
por: Finsterer, Josef
Publicado: (2022) -
SARS-CoV-2 infection and seroprevalence in patients with multiple sclerosis()
por: Piñar Morales, R., et al.
Publicado: (2021) -
A Case of Multiple Sclerosis Uncovered Following Moderna SARS-CoV-2 Vaccination
por: Ahoussougbemey Mele, Ange, et al.
Publicado: (2022)